Security key
05153U107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 36,866,668
- Total 13F value
- $329,191,609
- Share change
- -2,909,545
- Put/Call ratio
- 32%
- SEC-reported price per share
- $8.91
- Number of holders
- 81
- Value change
- -$25,783,402
- Number of buys
- 39
- Number of sells
- 27
- Shares outstanding
- 104,146,273
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
81
Top holders
10
AURA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Aura Biosciences, Inc. SEC filings
Aura Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05153U107
Recent filing periods:
Ownership snapshot
Top reported holders of AURA - Aura Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 6.6%
Showing 1-6 of 15 holder rows.
Quick read
Matrix Capital Management Company, LP leads the comparable SEC ownership view at 6.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership
Top 5
Matrix Capital Management Company...
6.6%
EVENTIDE ASSET MANAGEMENT, LLC
5.6%
ADAGE CAPITAL PARTNERS GP, L.L.C.
4.7%
Medicxi Ventures Management (Jers...
2.9%
BlackRock Finance, Inc.
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
Company
|
6.6%
|
$52,336,897
6,922,870 shares
|
— | 30 Jun 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
5.6%
|
$43,868,276
5,802,682 shares
|
— | 30 Jun 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
4.7%
|
$36,930,600
4,885,000 shares
|
— | 30 Jun 2024 |
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
Company · 10%+ Owner
|
2.9%
|
$22,981,584
3,039,892 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
2.9%
|
$22,720,537
3,005,362 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.2%
|
$17,680,308
2,338,665 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
81
Shares
36,866,668
Rows available
81
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
116
Q3 2024 holders
81
Holder diff
-35
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend